Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics, today announced that Dr. Andreas Grassauer, CEO, Pascal Schmidt, CFO, and Stephanie Kniep, Head of Investor Relations, will be attending several upcoming investor conferences where they will be available for meetings:
German Spring Conference
23 May 2022 – Frankfurt, Germany
Organized by Equity Forum, the annual German Spring Conference gives listed companies the opportunity to present to and connect with selected investors, analysts, financial journalists, and other capital market players.
Marinomed will attend on 23 May after presenting their Q1 financial results at 10:00 am CEST in a conference call. The presentation will be at 03:30 pm CEST.
All conferences are listed in the press release down below.
The full press release is available as download here: